AAAAAA

   
Results: 1-12 |
Results: 12
The potential use of urinary excretion data for assessing the relative bioavailability of rifampicin in fixed dose combination anti-tuberculosis formulations
Authors: Pillai, G Ellard, GA Smith, PJ Fourie, PB
Citation: G. Pillai et al., The potential use of urinary excretion data for assessing the relative bioavailability of rifampicin in fixed dose combination anti-tuberculosis formulations, INT J TUBE, 5(8), 2001, pp. 691-695
Evaluation of a rapid test for HIV antibodies in saliva and blood
Authors: Webber, LM Swanevelder, C Grabow, WOK Fourie, PB
Citation: Lm. Webber et al., Evaluation of a rapid test for HIV antibodies in saliva and blood, S AFR MED J, 90(10), 2000, pp. 1004-1007
Universal pattern of RpoB gene mutations among multidrug-resistant isolates of Mycobacterium tuberculosis complex from Africa
Authors: Schilke, K Weyer, K Bretzel, G Amthor, B Brandt, J Sticht-Groh, V Fourie, PB Haas, WH
Citation: K. Schilke et al., Universal pattern of RpoB gene mutations among multidrug-resistant isolates of Mycobacterium tuberculosis complex from Africa, INT J TUBE, 3(7), 1999, pp. 620-626
Mycobacterium bovis as a zoonosis in the Kruger National Park, South Africa
Authors: Weyer, K Fourie, PB Durrheim, D Lancaster, J Haslov, K Bryden, H
Citation: K. Weyer et al., Mycobacterium bovis as a zoonosis in the Kruger National Park, South Africa, INT J TUBE, 3(12), 1999, pp. 1113-1119
Rifampicin bioavailability: a review of its pharmacology and the chemotherapeutic necessity for ensuring optimal absorption
Authors: Ellard, GA Fourie, PB
Citation: Ga. Ellard et Pb. Fourie, Rifampicin bioavailability: a review of its pharmacology and the chemotherapeutic necessity for ensuring optimal absorption, INT J TUBE, 3(11), 1999, pp. S301-S308
Recent bioequivalence studies on fixed-dose combination anti-tuberculosis drug formulations available on the global market
Authors: Pillai, G Fourie, PB Padayatchi, N Onyebujoh, PC McIlleron, H Smith, PJ Gabriels, G
Citation: G. Pillai et al., Recent bioequivalence studies on fixed-dose combination anti-tuberculosis drug formulations available on the global market, INT J TUBE, 3(11), 1999, pp. S309-S316
Panel discussion I
Authors: Iseman, MD Fourie, PB Mitchison, DA Kaul, C Wang, J Roscigno, G Gangadharam, PRJ Ellard, G Pillai, C Mantala, J",Bakhle,"Spinaci, S Reichman, L Enarson, DA Binkin, N
Citation: Md. Iseman et al., Panel discussion I, INT J TUBE, 3(11), 1999, pp. S317-S321
The development of a standardised screening protocol for the in vivo assessment of rifampicin bioavailability
Authors: McIlleron, H Gabriels, G Smith, PJ Fourie, PB Ellard, GA
Citation: H. Mcilleron et al., The development of a standardised screening protocol for the in vivo assessment of rifampicin bioavailability, INT J TUBE, 3(11), 1999, pp. S329-S335
Panel discussion II
Authors: Iseman, MD Fourie, PB Mitchison, DA Kaul, C Wang, J Kenyon, T Panchagnula, R Pillai, C",Boman,Mika
Citation: Md. Iseman et al., Panel discussion II, INT J TUBE, 3(11), 1999, pp. S351-S352
Proposed minimum registration requirements for fixed-dose combination anti-tuberculosis drugs
Authors: Fourie, PB
Citation: Pb. Fourie, Proposed minimum registration requirements for fixed-dose combination anti-tuberculosis drugs, INT J TUBE, 3(11), 1999, pp. S362-S367
Structures required, roles and responsibilities in maintaining laboratories for quality assurance of anti-tuberculosis fixed-dose combinations in accordance with the IUATLD/WHO statement
Authors: Fourie, PB Spinaci, S
Citation: Pb. Fourie et S. Spinaci, Structures required, roles and responsibilities in maintaining laboratories for quality assurance of anti-tuberculosis fixed-dose combinations in accordance with the IUATLD/WHO statement, INT J TUBE, 3(11), 1999, pp. S368-S370
Panel discussion III
Authors: Iseman, MD Spinaci, S Weil, D Coulibaly, IM Cruz, R Mantala, J Roscigno, G",Bakhle,"Trebucq, A Ellard, G Mitchison, DA Fourie, PB de Goege, M Frieden, T Ottmani, S
Citation: Md. Iseman et al., Panel discussion III, INT J TUBE, 3(11), 1999, pp. S381-S387
Risultati: 1-12 |